Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Intra-Cellular Therapies Total Assets 2013-2019 | ITCI

Intra-Cellular Therapies total assets from 2013 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Intra-Cellular Therapies Annual Total Assets
(Millions of US $)
2018 $357
2017 $471
2016 $389
2015 $484
2014 $131
2013 $38
2012 $20
Intra-Cellular Therapies Quarterly Total Assets
(Millions of US $)
Q1 2019 $343
Q4 2018 $357
Q3 2018 $386
Q2 2018 $412
Q1 2018 $446
Q4 2017 $471
Q3 2017 $334
Q2 2017 $350
Q1 2017 $372
Q4 2016 $389
Q3 2016 $543
Q2 2016 $448
Q1 2016 $464
Q4 2015 $484
Q3 2015 $513
Q2 2015 $213
Q1 2015 $237
Q4 2014 $131
Q3 2014 $138
Q2 2014 $141
Q1 2014 $147
Q4 2013 $38
Q3 2013 $47
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.732B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $114.125B 12.90
Gilead Sciences (GILD) United States $88.452B 10.74
Celgene (CELG) United States $69.757B 11.82
Illumina (ILMN) United States $53.149B 61.60
Vertex Pharmaceuticals (VRTX) United States $47.119B 56.96
Biogen (BIIB) United States $46.358B 8.80
Regeneron Pharmaceuticals (REGN) United States $34.997B 16.45
Alexion Pharmaceuticals (ALXN) United States $29.687B 16.80
Incyte (INCY) United States $19.021B 77.13
BioMarin Pharmaceutical (BMRN) United States $15.742B 0.00
Exact Sciences (EXAS) United States $14.936B 0.00
Seattle Genetics (SGEN) United States $11.573B 0.00
Array BioPharma (ARRY) United States $10.245B 0.00
Sarepta Therapeutics (SRPT) United States $9.631B 0.00
QIAGEN (QGEN) Netherlands $9.180B 30.16
Bio-Techne Corp (TECH) United States $7.965B 54.34
Alnylam Pharmaceuticals (ALNY) United States $7.923B 0.00
Guardant Health (GH) United States $7.707B 0.00
Bluebird Bio (BLUE) United States $6.608B 0.00
Galapagos (GLPG) Belgium $6.528B 0.00
Exelixis (EXEL) United States $6.449B 16.44
Amarin (AMRN) Ireland $6.286B 0.00
BeiGene (BGNE) Cayman Islands $5.662B 0.00
Ascendis Pharma (ASND) Denmark $5.157B 0.00
Moderna (MRNA) United States $4.836B 0.00
Blueprint Medicines (BPMC) United States $4.649B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.509B 0.00
Spark Therapeutics (ONCE) United States $4.036B 0.00
Repligen (RGEN) United States $3.922B 97.69
ACADIA Pharmaceuticals (ACAD) United States $3.748B 0.00
China Biologic Products (CBPO) China $3.739B 23.75
Mirati Therapeutics (MRTX) United States $3.657B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.598B 0.00
Global Blood Therapeutics (GBT) United States $3.554B 0.00
Alkermes (ALKS) Ireland $3.544B 0.00
Allogene Therapeutics (ALLO) United States $3.261B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.163B 0.00
UniQure (QURE) Netherlands $3.107B 0.00
Amicus Therapeutics (FOLD) United States $2.855B 0.00
Arena Pharmaceuticals (ARNA) United States $2.840B 5.77
Medicines (MDCO) United States $2.690B 0.00
Lion Biotechnologies (IOVA) United States $2.669B 0.00
Reata Pharmaceuticals (RETA) United States $2.627B 0.00
Immunomedics (IMMU) United States $2.513B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.424B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.403B 0.00
Halozyme Therapeutics (HALO) United States $2.391B 0.00
Emergent Biosolutions (EBS) United States $2.382B 20.69
Akcea Therapeutics (AKCA) United States $2.251B 0.00
NeoGenomics (NEO) United States $2.230B 146.00
Ligand Pharmaceuticals (LGND) United States $2.200B 18.22
MyoKardia (MYOK) United States $2.185B 0.00
Acceleron Pharma (XLRN) United States $2.117B 0.00
Insmed (INSM) United States $2.078B 0.00
Genomic Health (GHDX) United States $2.033B 43.18
Zai Lab Unsponsored ADR (ZLAB) China $1.963B 0.00
REGENXBIO (RGNX) United States $1.949B 0.00
Denali Therapeutics (DNLI) United States $1.920B 0.00
Allakos (ALLK) United States $1.908B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.828B 0.00
Audentes Therapeutics (BOLD) United States $1.789B 0.00
Myriad Genetics (MYGN) United States $1.726B 17.17
AnaptysBio (ANAB) United States $1.601B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.540B 0.00
Apellis Pharmaceuticals (APLS) United States $1.522B 0.00
Coherus BioSciences (CHRS) United States $1.510B 0.00
Gossamer Bio (GOSS) United States $1.508B 0.00
Cambrex (CBM) United States $1.484B 18.77
Innoviva (INVA) United States $1.438B 3.98
Epizyme (EPZM) United States $1.360B 0.00
Fate Therapeutics (FATE) United States $1.297B 0.00
Alector (ALEC) United States $1.253B 0.00
Aimmune Therapeutics (AIMT) United States $1.250B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.214B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.207B 0.00
Athenex (ATNX) United States $1.203B 0.00
Sangamo Therapeutics (SGMO) United States $1.148B 0.00
Editas Medicine (EDIT) United States $1.124B 0.00
Rubius Therapeutics (RUBY) United States $1.095B 0.00
RA PHARMCTL INC (RARX) United States $1.079B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.059B 0.00
Codexis (CDXS) United States $1.050B 0.00
G1 THERAPEUTICS (GTHX) United States $1.045B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.001B 0.00
Atara Biotherapeutics (ATRA) United States $0.993B 0.00
Eidos Therapeutics (EIDX) United States $0.990B 0.00
Twist Bioscience (TWST) United States $0.976B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.969B 0.00
CORTEXYME INC (CRTX) United States $0.963B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.959B 0.00
ANI Pharmaceuticals (ANIP) United States $0.928B 16.46
NGM Biopharmaceuticals (NGM) United States $0.911B 0.00
WAVE Life Sciences (WVE) Singapore $0.897B 0.00
Principia Biopharma (PRNB) United States $0.859B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.852B 0.00
Retrophin (RTRX) United States $0.847B 0.00
Cara Therapeutics (CARA) United States $0.820B 0.00
Vericel (VCEL) United States $0.805B 0.00
Axsome Therapeutics (AXSM) United States $0.805B 0.00
Clovis Oncology (CLVS) United States $0.797B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.769B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.764B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.758B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.758B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.745B 35.15
Precision BioSciences (DTIL) United States $0.741B 0.00
Kura Oncology (KURA) United States $0.740B 0.00
Adverum Biotechnologies (ADVM) United States $0.727B 0.00
MeiraGTx Holdings (MGTX) United States $0.710B 0.00
Arvinas (ARVN) United States $0.708B 0.00
Stemline Therapeutics (STML) United States $0.695B 0.00
Zymeworks (ZYME) Canada $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.673B 0.00
Myovant Sciences (MYOV) United Kingdom $0.672B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.655B 0.00
Heska (HSKA) United States $0.650B 66.53
Zealand Pharma (ZEAL) Denmark $0.650B 7.59
Cytokineticsorporated (CYTK) United States $0.646B 0.00
Cellectis (CLLS) France $0.633B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.631B 0.00
Viking Therapeutics (VKTX) United States $0.577B 0.00
Anika Therapeutics (ANIK) United States $0.571B 19.51
Milestone Pharmaceuticals (MIST) Canada $0.552B 0.00
Magenta Therapeutics (MGTA) United States $0.545B 0.00
Puma Biotechnology (PBYI) United States $0.533B 0.00
ObsEva SA (OBSV) Switzerland $0.527B 0.00
Revance Therapeutics (RVNC) United States $0.514B 0.00
DBV Technologies (DBVT) France $0.504B 0.00
CytomX Therapeutics (CTMX) United States $0.496B 0.00
Sorrento Therapeutics (SRNE) United States $0.482B 0.00
BeyondSpring (BYSI) United States $0.477B 0.00
UROGEN PHARMA (URGN) United States $0.475B 0.00
Provention Bio (PRVB) United States $0.458B 0.00
Kodiak Sciences (KOD) United States $0.443B 0.00
Mesoblast (MESO) Australia $0.441B 0.00
Synthorx (THOR) United States $0.434B 0.00
Replimune (REPL) United States $0.427B 0.00
Krystal Biotech (KRYS) United States $0.421B 0.00
Arcus Biosciences (RCUS) United States $0.420B 0.00
MediciNova (MNOV) United States $0.418B 0.00
Agenus (AGEN) United States $0.403B 0.00
UNITY Biotechnology (UBX) $0.398B 0.00
BioDelivery Sciences (BDSI) United States $0.394B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.389B 0.00
Prothena (PRTA) Ireland $0.388B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.387B 0.00
Kaleido Biosciences (KLDO) $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
Scholar Rock Holding (SRRK) United States $0.383B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Albireo Pharma (ALBO) United States $0.376B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
ResTORbio (TORC) United States $0.370B 0.00
AC Immune SA (ACIU) Switzerland $0.369B 23.74
Biofrontera AG Sponsored ADR (BFRA) Germany $0.364B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.364B 0.00
Acorda Therapeutics (ACOR) United States $0.360B 6.35
AVROBIO (AVRO) United States $0.360B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
NuCana Sponsored ADR (NCNA) United Kingdom $0.348B 0.00
LogicBio Therapeutics (LOGC) United States $0.344B 0.00
Senesco Technologies (ELOX) United States $0.337B 0.00
Merus (MRUS) Netherlands $0.324B 0.00
Kindred Biosciences (KIN) United States $0.323B 0.00
NEXTCURE INC (NXTC) United States $0.321B 0.00
PHASEBIO PHARMA (PHAS) United States $0.307B 0.00
Cyclerion Therapeutics (CYCN) United States $0.305B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.303B 0.00
Evelo Biosciences (EVLO) United States $0.302B 0.00
Syros Pharmaceuticals (SYRS) United States $0.290B 0.00
Protagonist Therapeutics (PTGX) United States $0.281B 0.00
Geron (GERN) United States $0.276B 0.00
XBiotech (XBIT) United States $0.272B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Cellular Biomedicine (CBMG) United States $0.271B 0.00
Athersys (ATHX) United States $0.264B 0.00
Constellation Pharmaceuticals (CNST) United States $0.263B 0.00
Inovio Pharmaceuticals (INO) United States $0.257B 0.00
Dynavax Technologies (DVAX) United States $0.254B 0.00
Urovant Sciences (UROV) United States $0.250B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Neothetics (EVFM) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.242B 0.00
Chiasma (CHMA) United States $0.240B 0.00
Synlogic (SYBX) United States $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.234B 0.00
AXCELLA HEALTH (AXLA) United States $0.229B 0.00
Five Prime Therapeutics (FPRX) United States $0.227B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Kadmon Holdings (KDMN) United States $0.227B 0.00
Celcuity (CELC) United States $0.226B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.224B 0.00
Kamada (KMDA) Israel $0.219B 8.52
Avid Bioservices (CDMO) United States $0.216B 0.00
MannKind (MNKD) United States $0.216B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Cerecor (CERC) United States $0.214B 0.00
Affimed (AFMD) Germany $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
ChromaDex (CDXC) United States $0.211B 0.00
Enochian BioSciences (ENOB) United States $0.211B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.206B 0.00
Compugen (CGEN) Israel $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
Arsanis (XFOR) United States $0.193B 0.00
Kala Pharmaceuticals (KALA) United States $0.190B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
IDEAYA BIOSCI (IDYA) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 10.41
Gamida Cell (GMDA) Israel $0.180B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.175B 0.00
BioXcel Therapeutics (BTAI) United States $0.173B 0.00
Enzo Biochem (ENZ) United States $0.172B 0.00
Anavex Life Sciences (AVXL) United States $0.171B 0.00
OSMOTICA PHARM (OSMT) United States $0.170B 0.00
OvaScience (MLND) United States $0.164B 0.00
Mustang Bio (MBIO) United States $0.162B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
HOOKIPA PHARMA (HOOK) United States $0.159B 0.00
Axovant Sciences (AXGT) United States $0.156B 0.00
Cue Biopharma (CUE) United States $0.156B 0.00
Kezar Life Sciences (KZR) United States $0.153B 0.00
TREVI THERAPTCS (TRVI) United States $0.153B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
Aduro Biotech (ADRO) United States $0.149B 0.00
APPLIED THERAPT (APLT) United States $0.147B 0.00
XOMA (XOMA) United States $0.145B 0.00
TOCAGEN INC (TOCA) United States $0.144B 0.00
Intec Pharma (NTEC) Israel $0.144B 0.00
Checkpoint Therapeutics (CKPT) United States $0.141B 0.00
Verastem (VSTM) United States $0.134B 0.00
Novavax (NVAX) United States $0.132B 0.00
Eton Pharmaceuticals (ETON) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Arbutus Biopharma (ABUS) Canada $0.125B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
Celyad SA (CYAD) Belgium $0.119B 0.00
Aptinyx (APTX) United States $0.117B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.115B 0.00
Aptose Biosciences (APTO) Canada $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
Fortress Biotech (FBIO) United States $0.112B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.109B 0.00
NantKwest (NK) United States $0.109B 0.00
Alcobra (ARCT) United States $0.105B 0.00
Equillium (EQ) United States $0.104B 0.00
INmune Bio (INMB) United States $0.101B 0.00
VBI Vaccines (VBIV) United States $0.099B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.099B 0.00
Allena Pharmaceuticals (ALNA) United States $0.097B 0.00
Trevena (TRVN) United States $0.093B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.092B 0.00
Selecta Biosciences (SELB) United States $0.092B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.088B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.087B 0.00
InflaRx (IFRX) Germany $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.076B 0.00
Signal Genetics (MGEN) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Unum Therapeutics (UMRX) United States $0.072B 0.00
Cohbar (CWBR) United States $0.071B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
OVID THERAPEUTC (OVID) United States $0.070B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Cocrystal Pharma (COCP) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.061B 0.00
Prima BioMed (IMMP) Australia $0.061B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Moleculin Biotech (MBRX) United States $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.056B 0.00
DiaMedica Therapeutics (DMAC) United States $0.055B 0.00
Zosano Pharma (ZSAN) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Ophthotech (ISEE) United States $0.054B 0.00
Curis (CRIS) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Eyenovia (EYEN) United States $0.053B 0.00
Organovo Holdings (ONVO) United States $0.052B 0.00
Hoth Therapeutics (HOTH) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.045B 0.00
Cidara Therapeutics (CDTX) United States $0.044B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.043B 0.00
Aptevo Therapeutics (APVO) United States $0.043B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.039B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.031B 0.00
Aytu Bioscience (AYTU) United States $0.031B 0.00
Edge Therapeutics (PDSB) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Bison Capital Acquisition (XYN) China $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Sophiris Bio (SPHS) United States $0.025B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
ATyr Pharma (LIFE) United States $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
OncoSec Medical (ONCS) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Aileron Therapeutics (ALRN) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Motif Bio Plc (MTFB) United States $0.011B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Neuralstem (CUR) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Stellar Biotechnologies (EDSA) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00
MEREO BIOPHARMA (MREO) $0.000B 0.00